Back
Mitek Systems Vs. Blueprint Medicines Industry Stock Comparison
Sell
50
MITK
Mitek Systems
Last Price:
$9.37
Seasonality Move:
10.53%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
50
Mitek Systems (MITK)
is a Sell
Is Mitek Systems a Buy, Sell or Hold?
-
The current Mitek Systems [MITK] share price is $9.44. The Score for MITK is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
MITK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MITK Stock Price Chart
What is Mitek Systems's stock price today?
-
The Mitek Systems share price today is $9.44Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MITK is experiencing slight selling pressure.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
MITK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.63 | Buy |
Relative Strength Index (14 RSI): | 41.65 | Sell |
Chaikin Money Flow: | -59162 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.5 - 10.1) | Sell |
Bollinger Bands (100): | (8.31 - 9.91) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.49 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.07 - 129.15) | Buy |
Bollinger Bands (100): | (85.79 - 122.45) | Buy |
MITK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.53 | Sell |
20-day SMA: | 9.83 | Sell |
50-day SMA: | 9.74 | Sell |
200-day SMA: | 9.38 | Buy |
8-day EMA: | 8.21 | Buy |
20-day EMA: | 5.24 | Buy |
50-day EMA: | 2.61 | Buy |
200-day EMA: | 0.73 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.38 | Buy |
20-day SMA: | 128.73 | Buy |
50-day SMA: | 119.37 | Buy |
200-day SMA: | 99.85 | Buy |
8-day EMA: | 129.26 | Buy |
20-day EMA: | 127.9 | Buy |
50-day EMA: | 120.09 | Buy |
200-day EMA: | 103.72 | Buy |
Mitek Systems Earnings Growth & MITK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.12 per share, an increase this year of $0.07 per share, and an increase next year of $0.14 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
Mitek Systems Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |